0
Your cart

Your cart is empty

Books > Medicine > Pre-clinical medicine: basic sciences > Anatomy > Cytology

Buy Now

PI3K-mTOR in Cancer and Cancer Therapy (Hardcover, 1st ed. 2016) Loot Price: R5,532
Discovery Miles 55 320
PI3K-mTOR in Cancer and Cancer Therapy (Hardcover, 1st ed. 2016): Nandini Dey, Pradip De, Brian Leyland-jones

PI3K-mTOR in Cancer and Cancer Therapy (Hardcover, 1st ed. 2016)

Nandini Dey, Pradip De, Brian Leyland-jones

Series: Cancer Drug Discovery and Development

 (sign in to rate)
Loot Price R5,532 Discovery Miles 55 320 | Repayment Terms: R518 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

In the post human-genome project era, cancer specific genomic maps are redesigning tumor taxonomy by evolving from histopathology to molecular pathology. The success of a cancer drug today is fundamentally based on the success in identifying target genes that control beneficial pathways. The overwhelming power of genomics and proteomics has enlightened researchers about the fact that the PI3K-mTOR pathway is the most commonly up-regulated signal transduction pathway in various cancers, either by virtue of its activation downstream of many cell surface growth factor receptors or by virtue of its collateral and compensatory circuitry with RAS-MAPK pathway. Oncogenic signaling in the majority of solid tumors is sustained via the PI3K-AKT-mTOR pathway. Because of its prominent role in many cancer types, the PI3K-mTOR pathway has become a major therapeutic target. The volume includes two complementary parts which address the problem of etiology and disease progression and is intended to portray the very basic mechanisms of the PI3K-AKT-mTOR signaling pathway's involvement in various facets of the cancer, including stem cell renewal, cell metabolism, angiogenesis, genetic instability, and drug resistance. Significant progress has been made in recent years elucidating the molecular mechanism of cancer cell proliferation, angiogenesis, and drug-resistance in relation to the PI3K-mTOR pathway and this volume provides an in-depth overview of recent developments made in this area.

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Cancer Drug Discovery and Development
Release date: June 2016
First published: 2016
Editors: Nandini Dey • Pradip De • Brian Leyland-jones
Dimensions: 235 x 155 x 19mm (L x W x T)
Format: Hardcover
Pages: 294
Edition: 1st ed. 2016
ISBN-13: 978-3-319-34209-2
Categories: Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Pre-clinical medicine: basic sciences > Anatomy > Cytology
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-319-34209-6
Barcode: 9783319342092

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners